mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.0003 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0004 |